Search
for
Sort by
Research 781–810 of 1000+
- Are hand preference and sexual orientation possible predicting factors for finasteride adverse effects in male androgenic alopecia?
- Sexual dysfunction in men taking systemic dermatologic medication: A systematic review
- Sexual Function and Depressive Symptoms in Young Women With Nonclassic Congenital Adrenal Hyperplasia
- Androgenetic alopecia: effects of oral finasteride on hormone profile, reproduction and sexual function
- Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors
- Exposure to non-persistent pesticides and sexual maturation of Spanish adolescent males
- Assessing dutasteride-associated sexual dysfunction using the U.S. Food and Drug Administration Adverse Event Reporting System
- Sexual health in rheumatology
- Sexual dimorphism following in vitro ischemia in the response to neurosteroids and mechanisms of injury
- Practical Geriatrics: Maintaining Sexual Health After Menopause
- Disproportional signal of sexual dysfunction reports associated with finasteride use in young men with androgenetic alopecia: A pharmacovigilance analysis of VigiBase
- The Conception and Evaluation of Sexual Health Literature
- Persistent Sexual Side Effects of Finasteride: Could They Be Permanent?
- Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis
- HPA Axis Variation and ACEs; Childhood Sexual Trauma is Associated with Lower Hair Cortisol in Adulthood
- Letter to the Editor: “Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss”
- Sexual dysfunction, including hypoactive sexual desire disorder: Diagnosis and treatment recommendations
- Sexual Medicine Reviews—The Premiere Review Journal for the Field of Sexual Medicine
- Sexual difference, identification and object choice in individuals with sex differentiation disorders
- Sexual Dimorphism in Micronutrient Homeostasis and Cluster Depletion Patterns in Type 2 Diabetes Mellitus Patients with Hair Loss: Development and Validation of a Phenotype-Based Risk Stratification Tool
- Sexual dysfunction associated with 5α-reductase inhibitors in the treatment of androgenetic alopecia: a systematic review
- Finasteride. dutasteride risk of suicide and sexual dysfunction
- Health consequences of anabolic steroids: a sexual-medicine perspective
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- An (Ir)reversible Affection of the Sexual Sphere: A Case Report
- Finasteride- versus dutasteride-related sexual AEs
- Evaluation of Sexual Dysfunctions in Male Patients with Androgenetic Alopecia
- Psychiatric and sexual dysfunction warnings strengthened for finasteride and dutasteride
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- 0885 The androgen-THY1 axis mediates sexual dimorphism in dermal adipogenesis and fibrosis